Aten Papers and Foam IPO Day 2 update: Subscription lags at 72%, GMP 10%

Aten Papers and Foam Day 2 subscription status: The initial public offering (IPO) of Aten Papers and Foam, an intermediary in the paper product supply chain, has received a tepid response from investors so far, with the issue still not fully subscribed. As per BSE data available at 10:25 AM on Monday, June 16, the SME IPO, has received applications for 23,86,800 shares out of the 33,00,000 shares available, resulting in a subscription rate of 72 per cent.
Aten Papers and Foam IPO grey market premium (IPO)
According to sources tracking unofficial market activities, the unlisted shares of Aten Papers were trading at around 106, reflecting a grey market premium of ₹10 or 10.4 per cent over the upper-end price of ₹96.
Aten Papers and Foam IPO details
Aten Papers aims to raise ₹31.68 crore through a fresh issue of 3.3 million equity shares. There is no offer for sale (OFS) component. The company has reserved not more than 50 per cent of the net issue for Qualified institutional buyers (QIBs), not less than 35 per cent for retail investors, and not less than 15 per cent for Non-institutional investors (NIIs). ALSO READ |
Investors can bid for a minimum of 1,200 shares of Aten Papers IPO, and in multiples thereof, with the minimum investment amount of ₹1,15,200 at the upper price band.
Aten Papers and Foam IPO allotment date, listing date
The public offering opened for bidding on Friday, June 13, and is slated to close for subscription on Tuesday, June 17. Following the closure of the subscription window, the basis of allotment of the company's shares is tentatively scheduled to take place on Wednesday, June 18, 2025. Shares of Aten Papers are scheduled to be listed on the BSE SME on Friday, June 20, 2025.
Aten Papers and Foam IPO registrar, lead manager
Aten Papers and Foam IPO objective
According to the red herring prospectus, Aten Papers plans to use the proceeds from the public offering for capital expenditure, working capital requirements, and issue expenses, as well as for general corporate purposes.
About Aten Papers and Foam
Incorporated in January 2019, Aten Papers and Foam operates as an intermediary in the paper product supply chain. As a middleman in the paper product supply chain, it procures paper from different paper mills and resells it to its clients in the packaging products industry. The company's product portfolio includes Kraft Papers and Suplex boards with a wide range of grades, thicknesses, widths, and standards.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

News18

an hour ago

• News18

Influx Healthtech IPO Receives Over 201.3x Subscription On Final Day Of Bidding; Check GMP Today

The GMP of the Influx Healthtech IPO is 18.75%, indicating strong listing gains for investors. Influx Healthtech IPO Day 3: The initial public offering of Influx Healthtech Ltd has been closed today, Friday, June 20. The IPO has received a strong response from investors. Till 5:00 pm on the final day of bidding on Friday, the Rs 55.63-crore SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The three-day IPO was opened on Wednesday, June 18. It received a 5.89 times subscription on Day 1 on Wednesday and a 25.47 times subscription on Day 2. Influx Healthtech IPO Price The price of the Influx Healthtech IPO has been fixed at Rs 96 apiece. Influx Healthtech IPO Lot Size The minimum lot size is 1,200 shares, requiring a retail investment of Rs 1,15,200. For NIIs, the minimum is 2 lots (2,400 shares) at Rs 2,30,400. According to market observers, the GMP of the Influx Healthtech IPO is 18.75%, indicating strong listing gains for investors. The 18.75% GMP is significantly lower than the 39.58% premium recording in the morning. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. The shares of Influx Healthtech Ltd will be listed on the NSE SME on June 25. The Eppeltone Engineers IPO is a book-built issue worth Rs 55.63 crore, comprising a fresh issue of 46.94 lakh equity shares worth Rs 45.07 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. The IPO opened for subscription on June 18, 2025, and will close on June 20, 2025. Share allotment is likely to be finalised on June 23, with the listing expected on the NSE SME platform on June 25, 2025. The price band is set at Rs 96 per share. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.

The Print

2 hours ago

• The Print

Markets snap 3-day losing run; Sensex jumps 1,000 pts as financial, telecom shares gain

The 50-share NSE Nifty climbed 319.15 points or 1.29 per cent to 25,112.40. A largely supportive trend overseas and renewed foreign capital inflows supported domestic equities following signs of easing tension in the Middle East, traders said. After a flat start, the BSE Sensex later found its mojo back and surged 1,046.30 points or 1.29 per cent to settle at 82,408.17. During the day, it jumped 1,132.62 points or 1.39 per cent to 82,494.49. Mumbai, Jun 20 (PTI) Equity benchmark indices Sensex and Nifty rebounded sharply by over 1 per cent on Friday after sliding for the past three sessions, propelled by bargain hunting in financial, telecom and tech stocks amid a correction in global crude prices. As many as 2,463 stocks advanced while 1,484 declined and 147 remained unchanged on the BSE. This week, the BSE benchmark gauge jumped 1,289.57 points or 1.58 per cent, and the Nifty surged 393.8 points or .59 per cent. 'Equity indices surged as Middle East tension moderated with risk of immediate military actions reduced as US dialogue with Iran is expected to take place. The development led the crude price to correct, favouring domestic markets and boosting foreign investors' sentiments. 'In the broader market, rapid fall in VIX index and buying was witnessed in rate sensitives and consumer-oriented sectors like Finance, Auto and Reality and in anticipation of better Q1FY26 results led by rate cuts benefits, drop in inflationary pressure and rebound in consumer spending,' Vinod Nair, Head of Research, Geojit Investments Limited, said. From the Sensex firms, Bharti Airtel, Nestle, Mahindra & Mahindra, Power Grid, Reliance Industries, NTPC, Eternal and HDFC Bank were among the biggest gainers. In contrast, Maruti was the only laggard. The BSE midcap gauge jumped 1.20 per cent, and smallcap index climbed 0.55 per cent. All BSE sectoral indices ended higher. Telecommunication surged 2.73 per cent, realty (2.22 per cent), teck (1.42 per cent), capital goods (1.17 per cent), bankex (1.15 per cent), consumer discretionary (1.12 per cent) and metal (1.10 per cent). 'Sentiment improved after the news report indicated a possible de-escalation in the Iran-Israel conflict, with the US signalling a delay in potential action, which led to a softening in crude oil prices. Additionally, consistent buying by FIIs in the cash segment further supported the market,' Ajit Mishra – SVP, Research, Religare Broking Ltd, said. In Asian markets, South Korea's Kospi and Hong Kong's Hang Seng settled in positive territory, while Japan's Nikkei 225 index and Shanghai's SSE Composite index ended lower. Markets in Europe were trading higher in mid-session trade. US markets were closed on Thursday for the Juneteenth holiday. Global oil benchmark Brent crude dropped 1.93 per cent to USD 77.33 a barrel. Foreign Institutional Investors (FIIs) bought equities worth Rs 934.62 crore on Thursday, according to exchange data. Domestic Institutional Investors (DIIs) also bought equities worth Rs 605.97 crore. On Thursday, the 30-share BSE Sensex declined 82.79 points, or 0.10 per cent, to settle at 81,361.87. The Nifty dipped 18.80 points or 0.08 per cent to 24,793.25. 'In the absence of any major domestic events, global markets will continue to guide sentiment. We maintain our positive yet cautious stance and advise focusing on stock selection, particularly in line with sectoral trends,' Mishra said. PTI SUM SUM BAL BAL This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Business Standard

3 hours ago

• Business Standard

Nippon India MF, BlackRock, others buy 10% stake in Sai Life for ₹1,505 cr

Nippon India Mutual Fund, BlackRock, Societe Generale, Morgan Stanley and others on Friday collectively bought a 10 per cent stake in Sai Life Sciences from US-based asset manager TPG for Rs 1,505 crore through open market transactions. Besides, Axis Mutual Fund (MF), Aditya Birla Sun Life MF, Invesco MF, Norway's Government Pension Fund Global, German multinational Allianz's arm Pimco, Axis Max Life Insurance, HDFC MF, Ghisallo Master Fund LP, UTI MF, DSP MF were among the buyers of Sai Life Sciences shares. These entities picked up more than 2.08 crore equity shares or 10 per cent stake in Hyderabad-based Sai Life Sciences, as per the block deal data on the BSE. The transaction, valued at around Rs 1,504.75 crore, was executed at an average price of Rs 722 apiece. Meanwhile, Nippon India MF picked up 49.86 lakh shares or 2.39 per cent holding in Sai Life Sciences. After the stake buy, Nippon India MF's stake in the company rose to 4.88 per cent from 2.48 per cent. Meanwhile, global asset manager TPG through its affiliate TPG Asia VII SF offloaded the equal number of shares in 25 tranches at the same price. Following the stake sale, TPG's holding in Sai Life Sciences declined to 14.73 per cent from 24.73 per cent. Shares of Sai Life Sciences rose 5.03 per cent to close at Rs 765.85 apiece on the BSE. In December last year, Sai Life Sciences raised Rs 3,043 crore through its initial public offering and the shares of the company made a stellar debut on the bourses. Sai Life Sciences provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities (NCE) to global pharmaceutical innovator companies and biotechnology firms.